Clotcast: Season 2 Episode 1


Drs. Lee Kirksey, Carlos Mena, and Jocelyn Beach talk about what PAD is, risk factors for PAD, signs/symptoms of PAD, and how PAD is diagnosed.

Moderator: Lee Kirksey MD, MBA
Special Guests: Jocelyn Beach, MD, MS and Carlos Mena, MD

View Podcast S2E1 Show Notes

Stay tuned for Clotcast Season 2 episodes launching every Friday in September 2023!

View all Clotcast Episodes:

Dr. Lee Kirksey is a board-certified vascular surgeon. He joined the Department of Vascular Surgery in the Sydell and Arnold Miller Heart, Vascular, and Thoracic Institute at The Cleveland Clinic in 2011. Dr. Kirksey holds the Walter W. Buckley Endowed Vice Chairman position and is the Chief Equity and Community Engagement Officer at the Cleveland Clinic.

Dr. Kirksey’s clinical areas of interest include minimally invasive and hybrid approaches to complex vascular disease. His research areas include the investigation of solutions that address healthcare disparities in underserved and minority groups and the delivery of value-based population healthcare. He is co-author of the book Your Guide to Optimal Health, which, contrary to his clinical practice as a surgeon, details an evidence-based prescription for a healthy lifestyle and disease prevention. He resides in Solon, Ohio with his wife Seema, and two sons Shyar and Nikash. 

Jocelyn Beach, MD, MS is a vascular surgeon and Assistant Professor of Surgery at Dartmouth-Hitchcock Medical Center. Both her clinical and research focus is  on peripheral artery disease and complex limb preservation.

Dr. Carlos Mena was born and raised in Colombia, S.A., where he received his MD degree at The University of Antioquia. He later moved to the United States, where he did his post-graduate training at Yale University including Internal Medicine, Cardiology, and interventional cardiology, he spent a dedicated year in advanced peripheral vascular interventions. He is nationally known, he is the national PI for several trials including Lutonix-ISR trials, he also has participated in other pivotal clinical trials for lower extremity PAD, including Levent-2, Levant BTK, Covidien Illuminate clinical trial, Excite –ISR and a number of carotid revascularization trials. His interests also expand to renal denervation and carotid intervention; currently participating in Reduce-HTN as well simplicity trials. He has multiple publications in peer review journals including NEJM, and JACC, and has lectured around the world on PAD-related topics. He is the Director of Vascular Medicine at Yale New Haven Hospital, the Co-Director of Critical Limb Ischemia for Yale New Haven Health System, and the Co-Director Vascular Medicine Outcomes Program, Section Cardiovascular Medicine.

Related Articles